<?xml version="1.0" encoding="UTF-8"?>
<p id="par0015">The different investigations carried out since then attribute to these 2 drugs an antiviral action dependent on multiple mechanisms, sometimes replicated in 
 <italic>in vivo</italic> studies, and that, in the case of COVID-19, could include interference with glycosylation of the ACE2 receptor that the virus uses to bind to cells; the inhibition of the quinone reductase 2 enzyme, involved in the synthesis of sialic acids, which act as ligands for the virus; the alkalinization of endosomes and the inhibition of kinases such as MAPK, among others.
 <xref rid="bib0130" ref-type="bibr">3</xref>, 
 <xref rid="bib0135" ref-type="bibr">4</xref>
</p>
